Pharmacyte Biotech Inc (PMCB) stock has fallen -26.17% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives PMCB stock a score of 18 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 22. PMCB's rank also includes a short-term technical score of 32.
PMCB has an Overall Score of 18. Find out what this means to you and get the rest of the rankings on PMCB!
Pharmacyte Biotech Inc (PMCB) stock is unchanged 0.01% while the S&P 500 is up 0.09% as of 12:25 PM on Thursday, Jan 18. PMCB is unchanged $0.00 from the previous closing price of $2.20 on volume of 48,179 shares. Over the past year the S&P 500 has risen 20.73% while PMCB has fallen -26.17%. PMCB lost -$1.00 per share in the over the last 12 months.
Click Here to get the full Stock Report for Pharmacyte Biotech Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
